Expert Illustrations

Learning Objectives

Upon completion of this activity, participants should be better able to:

• Describe the mechanisms of chronic active antibody mediated renal transplant rejection (RTR)
• Apply guideline recommendations to the treatment of renal transplant recipients with cABMR
• Assess clinical trial data for emerging and investigational agents to treat cABMR